Rare diseases do not receive enough attention for the impact they have on patients and their families. This is what AlphaRose’s founder and CEO Casey McPherson learned after his daughter was diagnosed with a rare condition. In a conversation with host Ari Berman, McPherson shares how he switched from music to founding his own pharmaceutical company, what technologies AlphaRose is developing, and how his company is creating environments that allow innovation and iteration. He also shares his t...
All content for Trends from the Trenches is the property of Bio-IT World and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
Rare diseases do not receive enough attention for the impact they have on patients and their families. This is what AlphaRose’s founder and CEO Casey McPherson learned after his daughter was diagnosed with a rare condition. In a conversation with host Ari Berman, McPherson shares how he switched from music to founding his own pharmaceutical company, what technologies AlphaRose is developing, and how his company is creating environments that allow innovation and iteration. He also shares his t...
Episode: 31 - Tom Plasterer on Going From Pharma to Start-Up, Graph Technology, and More
Trends from the Trenches
29 minutes
1 year ago
Episode: 31 - Tom Plasterer on Going From Pharma to Start-Up, Graph Technology, and More
In this episode of Trends from the Trenches, host Stan Gloss speaks with industry veteran Tom Plasterer, managing director of life sciences innovation at XponentL Data. Plasterer shares his journey of how he became an industry leader, how his time at BG Medicine (then known as Beyond Genomics) helped him with his time at AstraZeneca, what graph technology is and its benefits, and why he returned to start-up companies with XponentL Data. He also gives advice based on his 20+ years of experienc...
Trends from the Trenches
Rare diseases do not receive enough attention for the impact they have on patients and their families. This is what AlphaRose’s founder and CEO Casey McPherson learned after his daughter was diagnosed with a rare condition. In a conversation with host Ari Berman, McPherson shares how he switched from music to founding his own pharmaceutical company, what technologies AlphaRose is developing, and how his company is creating environments that allow innovation and iteration. He also shares his t...
